DK2107870T3 - Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom - Google Patents

Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom Download PDF

Info

Publication number
DK2107870T3
DK2107870T3 DK08713353.4T DK08713353T DK2107870T3 DK 2107870 T3 DK2107870 T3 DK 2107870T3 DK 08713353 T DK08713353 T DK 08713353T DK 2107870 T3 DK2107870 T3 DK 2107870T3
Authority
DK
Denmark
Prior art keywords
enema
treatment
inflammatory bowel
bowel disease
irritant effect
Prior art date
Application number
DK08713353.4T
Other languages
English (en)
Inventor
Bala Venkataraman
Lindsey Brown
Daxa Patel
Original Assignee
Alaven Pharmaceutical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alaven Pharmaceutical Llc filed Critical Alaven Pharmaceutical Llc
Application granted granted Critical
Publication of DK2107870T3 publication Critical patent/DK2107870T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
    • B65D81/268—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants the absorber being enclosed in a small pack, e.g. bag, included in the package

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08713353.4T 2007-01-29 2008-01-29 Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom DK2107870T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89807207P 2007-01-29 2007-01-29
US11/749,732 US7645801B2 (en) 2007-01-29 2007-05-16 Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
PCT/US2008/001253 WO2008094618A2 (en) 2007-01-29 2008-01-29 Improved reduced irritant enema for the treatment of inflammatory bowel disease (ibd)

Publications (1)

Publication Number Publication Date
DK2107870T3 true DK2107870T3 (da) 2016-04-11

Family

ID=39668797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08713353.4T DK2107870T3 (da) 2007-01-29 2008-01-29 Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom

Country Status (8)

Country Link
US (2) US7645801B2 (da)
EP (1) EP2107870B1 (da)
AU (1) AU2008211124B2 (da)
CA (1) CA2677095C (da)
DK (1) DK2107870T3 (da)
ES (1) ES2567068T3 (da)
NZ (1) NZ578674A (da)
WO (1) WO2008094618A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EA020856B1 (ru) 2009-02-16 2015-02-27 Джулиани Интернэшнл Лимитед Способы лечения патологических состояний, связанных с волосами
CA2807242C (en) 2010-08-04 2017-05-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
EP2844242A1 (en) 2012-04-18 2015-03-11 Nogra Pharma Limited Methods of treating lactose intolerance
CA2997915A1 (en) 2015-09-15 2017-03-23 C.B. Fleet Company, Incorporated Bisacodyl compositions and delivery apparatus
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
US10098898B1 (en) 2017-12-04 2018-10-16 Handa Pharmaceuticals, Llc Release stable mesalamine dosage forms
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
WO2021145830A1 (en) * 2020-01-16 2021-07-22 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Pharmaceutical compositions comprising mesalamine and relevant excipients in the treatment of ulcerative colitis
CN115515435A (zh) * 2020-02-11 2022-12-23 沃尔夫森医疗中心 有效治疗溃疡性结肠炎的方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2647853A (en) 1949-11-29 1953-08-04 Lab Francais Chimiotherapie Injectable solution of salt of para-aminosalicylic acid
US3088870A (en) 1958-11-25 1963-05-07 Mcdermott Charles Byron Low volume contact laxative enema compositions
US4150744A (en) 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
US4211777A (en) 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
DE3027013A1 (de) 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln
US4440763A (en) 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
US4657930A (en) * 1981-10-09 1987-04-14 Baylor College Of Medicine Mitotic inhibitors preventing posterior lens capsule opacification
DE3151196A1 (de) 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
DE3323702A1 (de) 1983-07-01 1985-01-10 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin 5-aminosalicylsaeure-o-sulfate von physiologisch unbedenklichen basen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
USRE33239E (en) 1983-09-06 1990-06-26 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
US4832921A (en) * 1985-12-27 1989-05-23 Uop Inc. Apparatus for regeneration of hydrocarbon conversion catalyst
US5270337A (en) * 1987-09-25 1993-12-14 The Pillsbury Company Oxygen removal
US5120336A (en) * 1988-09-12 1992-06-09 Leblanc Thomas F Flow constriction device in radiator steam trap
GB8909559D0 (en) 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5010069A (en) 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
US5378470A (en) 1989-07-25 1995-01-03 Henning Berlin Gmbh Rectally administered pharmaceutical preparation
US5120306A (en) 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
KR100193933B1 (ko) 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
IT1243379B (it) 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
CA2062083C (en) * 1991-04-02 2002-03-26 Drew Ve Speer Compositions, articles and methods for scavenging oxygen
DE59202096D1 (de) 1991-06-07 1995-06-08 Byk Gulden Lomberg Chem Fab Pharmazeutische klistierzubereitung.
DK66493D0 (da) 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
DE69430373T2 (de) * 1993-08-06 2002-12-12 Smithkline Beecham S.P.A., Baranzate Di Bollate Hydroisochinolinderivate
FR2713486B1 (fr) 1993-12-14 1996-02-09 Scophysa Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues.
FR2738150B1 (fr) 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
KR100481300B1 (ko) 1995-09-08 2005-07-29 제이. 유라이어크 이 콤파니아 소시에떼아노님 염증성장질환치료용의5-아미노살리실산의아조유도체
IT1277663B1 (it) 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
CA2274943A1 (en) 1998-06-17 1999-12-17 Stephen L. Wolman Compositions for the treatment and prevention of inflammatory diseases of the gastrointestinal tract and methods and uses thereof
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
WO2002067936A1 (en) 2001-02-21 2002-09-06 Cell Pathways, Inc. Methods for treatment of inflammatory bowel disease
EP1312368A1 (de) 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Zusammensetzungen enthaltend Mesalazin zur Behandlung von entzündlichen Darmerkrankungen
WO2004093883A2 (en) 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
US7312243B1 (en) * 2003-08-29 2007-12-25 Jay Pravda Materials and methods for treatment of gastrointestinal disorders
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
JP4593469B2 (ja) 2003-09-22 2010-12-08 杏林製薬株式会社 変色改善された５−アミノサリチル酸固形製剤およびその保存方法
US20060264409A1 (en) 2004-01-20 2006-11-23 Harty Richard F Compositions and methods of treatment for inflammatory diseases
AU2004314731B2 (en) 2004-01-20 2011-07-07 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
US7645831B2 (en) * 2004-03-26 2010-01-12 Henkel Ag & Co. Kgaa Reactive hot melt adhesives
WO2005107479A1 (en) * 2004-04-29 2005-11-17 Research Development Foundation Oxidation of sulfites with chloroplast
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
KR20070100720A (ko) 2004-12-27 2007-10-11 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 임의로 산소 스캐빈저를 포함하는 산소-불투과성 포장,안정화된 갑상선 호르몬 조성물 및 갑상선 호르몬 약제학적조성물의 보관 방법
US20060270635A1 (en) 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
WO2007047028A1 (en) 2005-10-14 2007-04-26 Atrium Medical Corporation Packaging and sterilization of medical devices
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)

Also Published As

Publication number Publication date
ES2567068T3 (es) 2016-04-19
AU2008211124A1 (en) 2008-08-07
WO2008094618A3 (en) 2008-12-24
WO2008094618A2 (en) 2008-08-07
AU2008211124B2 (en) 2012-01-19
CA2677095A1 (en) 2008-08-07
US20100087537A1 (en) 2010-04-08
US20080183142A1 (en) 2008-07-31
US8217082B2 (en) 2012-07-10
NZ578674A (en) 2012-10-26
EP2107870A2 (en) 2009-10-14
EP2107870B1 (en) 2016-01-27
EP2107870A4 (en) 2012-05-09
US7645801B2 (en) 2010-01-12
CA2677095C (en) 2013-01-15

Similar Documents

Publication Publication Date Title
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
GB2450974B (en) Treatment of inflammatory bowel disease with cannabinoids
DK2214677T3 (da) Sammensætninger til behandling af inflammation i mavetarmkanalen
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
EP2124523A4 (en) BREEDING LINE P2428-5006090
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0911998A2 (pt) métodos e kits para o tratamento de condições de desordem inflamatória intestinal
DK2047863T3 (da) Middel til forebyggelse eller behandling af inflammatoriske sygdomme
DK2187882T3 (da) Behandling af progressiv neurodegenerativ sygdom med ibudilast
DK2211846T3 (da) Hidtil ukendte tilgange til behandling af CMT- og beslÇgtede lidelser
BRPI0812247A2 (pt) Derivados de piridazinona
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2111555T3 (da) Diagnosticering af præeklampsi
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DE602008006709D1 (de) Funduskamera
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
EP2110789A4 (en) PAPER MONEY PROCESSOR
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2022504T3 (da) Salve til behandling af hæmorider
DK2903629T3 (da) Antistofkonjugat til anvendelse ved behandling af inflammatorisk tarmsygdom
DK2099446T3 (da) Fremgangsmåde til behandling af inflammatorisk tarmsygdom